Skip to main content

Advertisement

SpringerLink
Log in

Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Self-expandable metal stents (SEMS) are the current standard of care for the palliative management of malignant biliary strictures. Recently, endoscopic ablative techniques with direct affect to local tumor have been developed to improve SEMS patency. Several reports have demonstrated the technical feasibility and safety of intraductal radiofrequency ablation (RFA), by both endoscopic and percutaneous approaches, in palliation of malignant strictures of the bile duct. Intraductal RFA has also been used in the treatment of occlusion of both covered and uncovered SEMS occlusion from tumor ingrowth or overgrowth. This article provides a comprehensive review of intraductal RFA in the management of malignant biliary obstruction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. McGorisk T, Krishnan K, Keefer L, Komanduri S. Radiofrequency ablation for refractory gastric antral vascular ectasia (with video). Gastrointest Endosc. 2013;78:584–588.

    Article  PubMed  Google Scholar 

  2. Dray X, Repici A, Gonzalez P, et al. Radiofrequency ablation treatment of gastric antral vascular ectasia: results from an international collaborative study. Gastrointest Endosc. 1040;77:AB180.

    Google Scholar 

  3. Nikfarjam M, Faulx A, Laughinghouse M, Marks JM. Feasibility of radiofrequency ablation for the treatment of chronic radiation proctitis. Surg Innov. 2010;17:92–94.

  4. Zhou C, Adler DC, Becker L, et al. Effective treatment of chronic radiation proctitis using radiofrequency ablation. Therap Adv Gastroenterol. 2009;2:149–156.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rustagi T, Mashimo H. Endoscopic management of chronic radiation proctitis. World journal of gastroenterology : WJG. 2011;17:4554–4562.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Eddi R, Depasquale JR. Radiofrequency ablation for the treatment of radiation proctitis: a case report and review of literature. Therap Adv Gastroenterol. 2013;6:69–76.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008;40:380–387.

    Article  PubMed  CAS  Google Scholar 

  8. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–195.

    Article  PubMed  Google Scholar 

  9. Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011;141:460–468.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wolf DS, Dunkin BJ, Ertan A. Endoscopic radiofrequency ablation of Barrett’s esophagus. Surg Technol Int. 2012;22:83–89.

    PubMed  Google Scholar 

  11. Lin ZZ, Shau WY, Hsu C, et al. Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size. PLoS ONE. 2013;8:e80276.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Peng ZW, Liu FR, Ye S, et al. Radiofrequency ablation versus open hepatic resection for elderly patients (>65 years) with very early or early hepatocellular carcinoma. Cancer. 2013;119:3812–3820.

    Article  PubMed  Google Scholar 

  13. Geyik S, Akhan O, Abbasoglu O, et al. Radiofrequency ablation of unresectable hepatic tumors. Diagn Interv Radiol. 2006;12:195–200.

    PubMed  Google Scholar 

  14. Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007;244:599–607.

    Article  PubMed  Google Scholar 

  15. Cirocchi R, Trastulli S, Boselli C, et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317.

    PubMed  Google Scholar 

  16. Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619–2626.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508–520.

    Article  PubMed  Google Scholar 

  18. Weng M, Zhang Y, Zhou D, et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS ONE. 2012;7:e45493.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Zou YP, Li WM, Zheng F, et al. Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer. World J Gastroenterol. 2010;16:5104–5110.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tang Z, Wu YL, Fang HQ, et al. Treatment of unresectable pancreatic carcinoma by radiofrequency ablation with ‘cool-tip needle’: report of 18 cases. Zhonghua yi xue za zhi. 2008;88:391–394.

    PubMed  Google Scholar 

  21. Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB. 2006;8:61–64.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Wu Y, Tang Z, Fang H, et al. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol. 2006;94:392–395.

    Article  PubMed  Google Scholar 

  23. Carrafiello G, Lagana D, Cotta E, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol. 2010;33:835–839.

    Article  PubMed  Google Scholar 

  24. Chiou YY, Hwang JI, Chou YH, Wang HK, Chiang JH, Chang CY. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci. 2005;21:304–309.

    Article  PubMed  Google Scholar 

  25. Fan WJ, Wu PH, Zhang L, et al. Radiofrequency ablation as a treatment for hilar cholangiocarcinoma. World J Gastroenterol. 2008;14:4540–4545.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Slakey DP. Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg. 2002;68:395–397.

    PubMed  Google Scholar 

  27. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005;100:2426–2430.

    Article  PubMed  CAS  Google Scholar 

  28. Zoepf T. Photodynamic therapy of cholangiocarcinoma. HPB. 2008;10:161–163.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  29. Pereira S HS, Roughton M, O’Donoghue P, Wasan H, Valle J, Bridgewater J. Photostent-02; Porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised phase III trial. ESMO. 2010; (Abstract No. 8020).

  30. Steel AW, Postgate AJ, Khorsandi S, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73:149–153.

    Article  PubMed  Google Scholar 

  31. Mizandari M, Pai M, Xi F, et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2013;36:814–819.

    Article  PubMed  Google Scholar 

  32. Itoi T, Isayama H, Sofuni A, et al. Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex vivo pig liver. J HepatoBiliary Pancreat Sci. 2012;19:543–547.

    Article  PubMed  Google Scholar 

  33. Mao EJ, Watson JB, Soares G, Habr FG. Successful Percutaneous Endobiliary radiofrequency ablation for unresectable malignant biliary obstruction: a case report and review of the literature. J Gastrointest Cancer. 2013; Aug 24.

  34. Khorsandi SZD, Vavra P. The modern use of radiofrequency energy in surgery, endoscopy and interventional radiology. Eur Surg. 2008;40:204–210.

    Article  Google Scholar 

  35. Zacharoulis D, Lazoura O, Sioka E, et al. Habib EndoHPB: a novel endobiliary radiofrequency ablation device. An experimental study. J Invest Surg.. 2013;26:6–10.

    Article  PubMed  Google Scholar 

  36. Figueroa-Barojas P, Bakhru MR, Habib NA, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol. 2013;2013:910897.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Alis H, Sengoz C, Gonenc M, Kalayci MU, Kocatas A. Endobiliary radiofrequency ablation for malignant biliary obstruction. Hepatobiliary Pancreat Dis Int. 2013;12:423–427.

    Article  PubMed  Google Scholar 

  38. Dolak W, Schreiber F, Schwaighofer H, et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28:854–860.

    Article  PubMed  Google Scholar 

  39. Pozsár J, Tarpay Á, Burai J, Pap A. Intraductal radiofrequency ablation can restore patency of occluded biliary self-expanding metal stents. Z Gastroenterol. 2011. doi:10.1055/s-0031-1278501.

  40. Monga A, Gupta R, Ramchandani M, Rao GV, Santosh D, Reddy DN. Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality (with videos). Gastrointest Endosc. 2011;74:935–937.

    Article  PubMed  Google Scholar 

  41. Mukund A, Arora A, Rajesh S, Bothra P, Patidar Y. Endobiliary radiofrequency ablation for reopening of occluded biliary stents: a promising technique. J Vasc Interv Radiol. 2013;24:142–144.

    Article  PubMed  Google Scholar 

  42. Pai M, Valek V, Tomas A, et al. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2014;37:235–240.

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT, 06520-8019, USA

    Tarun Rustagi & Priya A. Jamidar

Authors
  1. Tarun Rustagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priya A. Jamidar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tarun Rustagi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rustagi, T., Jamidar, P.A. Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction. Dig Dis Sci 59, 2635–2641 (2014). https://doi.org/10.1007/s10620-014-3237-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3237-9

Keywords

Search

Navigation